Pre-diagnostic vitamin D deficiency and subsequent thyroid cancer risk: a propensity-matched cohort study
Frontiers in Nutrition · 21.04.2026 · 13
DOI: 10.3389/fnut.2026.1817123 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Frontiers in Nutrition, online erschienen am 21.04.2026. Verfasst von Kuo-Chuan Hung und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Chi Mei Medical Center, Tainan City, Taiwan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Vitamin D deficiency (VDD) has been implicated as a potential risk factor for thyroid cancer; however, existing evidence is derived primarily from case-control or cross-sectional studies. This study aimed to examine the association between pre-diagnostic VDD and the risk of incident thyroid cancer over a 10-year follow-up period.
Methods
This retrospective propensity score–matched cohort study used the TriNetX Global Collaborative Network. Adults aged ≥ 18 y with serum 25-hydroxyvitamin D [25(OH)D] measurements between 2010 and 2023 were classified as having VDD (<20 ng/mL) or vitamin D sufficiency (≥30 ng/mL). One-to-one propensity score matching was performed on demographics, comorbidities, thyroid-related disorders, laboratory values, and vitamin D supplementation. The primary outcome was incident thyroid cancer ascertained ≥ 180 day after the index date (landmark approach) over 10 y of follow-up. Positive (osteoporotic fracture) and negative (appendicitis, goiter) control outcomes and thyroid procedure utilization were evaluated to assess detection bias.
Results
After matching, 571,669 pairs were analyzed over a median follow-up of 6.8 y. VDD was associated with an increased risk of incident thyroid cancer (HR: 1.41; 95% CI: 1.32, 1.50), and this risk was attenuated among patients with vitamin D insufficiency (25[OH]D 20–30 ng/mL; HR: 1.27; 95% CI: 1.20, 1.34), demonstrating a dose-dependent relationship. Thyroid biopsy and ultrasonography utilization were lower in the VDD cohort (HR: 0.95), arguing against detection bias. The positive control outcome (osteoporotic fracture; HR: 1.53) confirmed the validity of the exposure classification, whereas the negative control (appendicitis; HR: 1.02) showed no association. Findings were robust across all sensitivity and subgroup analyses.
Conclusion
Pre-diagnostic VDD was associated with increased thyroid cancer risk in a dose-dependent manner. These findings support further investigation of vitamin D status as a potentially modifiable risk factor for thyroid cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Chi Mei Medical Center, Tainan City, Taiwan.
- School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan.
- Department of Anesthesiology, E-Da Hospital, I-Shou University, Kaohsiung City, Taiwan.
- Department of Anesthesiology, Chi Mei Medical Center, Liouying, Tainan City, Taiwan.
Zitieren
APA
Hung, K. C., Kao, C. L., Yew, M., Lai, Y. C., & Chen, I. W. (2026). Pre-diagnostic vitamin D deficiency and subsequent thyroid cancer risk: a propensity-matched cohort study. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1817123
Vancouver
Hung KC, Kao CL, Yew M, Lai YC, Chen IW. Pre-diagnostic vitamin D deficiency and subsequent thyroid cancer risk: a propensity-matched cohort study. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1817123
BibTeX
@article{Hung2026,
author = {Hung, Kuo-Chuan and Kao, Chia-Li and Yew, Ming and Lai, Yi-Chen and Chen, I-Wen},
title = {Pre-diagnostic vitamin D deficiency and subsequent thyroid cancer risk: a propensity-matched cohort study},
journal = {Frontiers in Nutrition},
year = {2026},
volume = {13},
doi = {10.3389/fnut.2026.1817123}
}
EUVIMED